Efficacy and Safety of Trastuzumab, Capecitabine y Oxaliplatine as Treatment Gastric Cancer Metastatic (HER2)Positive

NCT01503983 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Stage IV Gastric Cancer With Metastasis

Interventions

DRUG: Trastuzumab
DRUG: Capecitabine
DRUG: Oxaliplatin

Sponsor

Fundación para el Progreso de la Oncología en Cantabria